Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Arginine Deprivation for Malignant Pleural Mesothelioma

October 27, 2016 By Law Offices of Thomas J. Lamb, P.A.

Arginine deprivation is a novel anticancer strategy in argininosuccinate synthetase 1 (ASS1)–negative tumors. In a multicenter, phase II trial, immunohistochemistry identified 68 patients with ASS1 deficiency among 201 patients with malignant pleural mesothelioma (MPM). The ASS1-deficient patients were randomized in a 2:1 ratio to either best … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, asbestos-related disease, mesothelioma, mesothelioma treatments

No Clinical Trials Comparing The Safety Of Eliquis To Xarelto Done Yet

October 26, 2016 By Law Offices of Thomas J. Lamb, P.A.

In two medical study reports it seemed that Xarelto (rivaroxaban) was more likely to be involved in a serious bleeding event as an adverse reaction than was either Pradaxa (dabigatran) or Eliquis (apixaban). Earlier this month the medical journal Chest published this article, “Direct comparison of dabigatran, rivaroxaban, and apixaban for … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding risk, Eliquis, Hemorrhages, Prad, Savaysa, Uncontrollable Bleeding Events, Xarelto

Scientists discover new option for treating malignant pleural mesothelioma

October 25, 2016 By Law Offices of Thomas J. Lamb, P.A.

Researchers at the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital have discovered a new option for treating malignant pleural mesothelioma. For the first time in the world, they were able to show in a preclinical study, both in the cell culture and in the animal model, that trabectedin, a chemotherapy drug that is already … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, asbestos-related disease, mesothelioma, mesothelioma treatments

Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review

October 20, 2016 By Law Offices of Thomas J. Lamb, P.A.

Abstract Background Desmoplastic malignant pleural mesothelioma (DMM) is rare histological subtype of diffuse malignant pleural mesothelioma (MPM), accounting for 5–10 % of cases. It has a poor prognosis, with direct invasion of the chest wall or lungs and distant metastases. Its pathological characteristics include dense collagen fibers in a … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos cancer, asbestos exposure, mesothelioma

Viagra – Melanoma MDL Might Include Cialis Lawsuits And Levitra Cases

October 19, 2016 By Law Offices of Thomas J. Lamb, P.A.

As regards drug injury lawsuits concerning the melanoma side effect of male erectile dysfunction (ED) pills, that litigation began with Viagra cases being filed against Pfizer, the drug company responsible for Viagra. By April 2016 there was a sufficient federal court Viagra lawsuits filed that the Judicial Panel on Multidistrict Litigation (JPML) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Cialis, Levitra, Melanoma, Viagra

Mesothelioma Treatment Center at Baylor St. Luke’s launches clinical trial for cancer patients

October 13, 2016 By Law Offices of Thomas J. Lamb, P.A.

The Baylor College of Medicine Mesothelioma Treatment Center at Baylor St. Luke’s Medical Center announced today that it has opened a new clinical trial that combines immunotherapy and surgery for the treatment of mesothelioma. This is the first in-human study of neoadjuvant (before surgery) administration of a checkpoint inhibitor immunotherapy … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos cancer, mesothelioma, mesothelioma treatments

Risk of Hepatitis B Reactivation Associated With Gleevec And Iclusig

October 12, 2016 By Law Offices of Thomas J. Lamb, P.A.

Currently available medicines in the BCR-ABL TKIs class of drugs include Gleevec and Iclusig, as well as Tasigna, Bosulif, and Sprycel. These BCR-ABL tyrosine kinase inhibitors (TKIs) are used for the treatment of specific types of blood cancers, including Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) and Ph+ acute … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Bosulif, Gleevec, Hepatitis, Iclusig, Sprycel, Tasigna

Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States

October 10, 2016 By Law Offices of Thomas J. Lamb, P.A.

Mesothelioma, a rare tumor, is highly correlated with asbestos exposure. Mesothelioma, similar to all asbestos-related diseases, is dose/intensity dependent to some degree, and studies showed the risk of mesothelioma rises with cumulative exposures. Multiple processes occur in an individual before mesothelioma occurs. The impact of mesothelioma in … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos cancer, asbestos exposure, asbestos-related disease, mesothelioma

Black-Box Warning For Harvoni, Sovaldi, Viekira Pak: Hepatitis B Risk

October 7, 2016 By Law Offices of Thomas J. Lamb, P.A.

Direct-acting antivirals (DAAs) are a class of prescription medicines that are FDA-approved to treat adults with hepatitis C virus (HCV) infection. These medicines are available as single-ingredient products and also in combination with other HCV medicines. Here is a list of direct-acting antivirals currently available in the US: Daklinza … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Daklinza, Epclusa, Harvoni, Hepatitis, Olysio, Sovaldi, Technivie, Viekira Pak, Zepatier

COA finds electrician can sue former employers for mesothelioma diagnosis

October 3, 2016 By Law Offices of Thomas J. Lamb, P.A.

The Indiana Court of Appeals held Wednesday that an electrician can sue his former employers for negligence and liability after he was exposed to asbestos. Larry Myers worked as an electrician for Koontz-Wagner Electric from 1961 to 1980, serving as an independent contract for companies such as Bremen Casting and Mastic Home Exteriors Inc. During … [Read more...]

Filed Under: Asbestos, Mesothelioma Tagged With: asbestos, asbestos exposure, asbestos lawsuits, mesothelioma, mesothelioma lawsuits

  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 66
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.